BACKGROUND: Uncomplicated skin and soft tissue infections are among the most frequent indications for outpatient antibiotics. A detailed understanding of current prescribing practices is necessary to optimize antibiotic use for these conditions. METHODS: This was a retrospective cohort study of children and adults treated in the ambulatory care setting for uncomplicated cellulitis, wound infection, or cutaneous abscess between March 1, 2010 and February 28, 2011. We assessed the frequency of avoidable antibiotic exposure, defined as the use of antibiotics with broad gram-negative activity, combination antibiotic therapy, or treatment for 10 or more days. Total antibiotic-days prescribed for the cohort were compared with antibiotic-days in 4 hypothetical short-course (5-7 days), single-antibiotic treatment models consistent with national guidelines. RESULTS: A total of 364 cases were included for analysis (155 cellulitis, 41 wound infection, and 168 abscess). Antibiotics active against methicillin-resistant Staphylococcus aureus were prescribed in 61% of cases of cellulitis. Of 139 cases of abscess where drainage was performed, antibiotics were prescribed in 80% for a median of 10 (interquartile range, 7-10) days. Of 292 total cases where complete prescribing data were available, avoidable antibiotic exposure occurred in 46%. This included use of antibiotics with broad gram-negative activity in 4%, combination therapy in 12%, and treatment for 10 or more days in 42%. Use of the short-course, single-antibiotic treatment strategies would have reduced prescribed antibiotic-days by 19% to 55%. CONCLUSIONS: Approximately half of uncomplicated skin infections involved avoidable antibiotic exposure. Antibiotic use could be reduced through treatment approaches using short courses of a single antibiotic.
BACKGROUND: Uncomplicated skin and soft tissue infections are among the most frequent indications for outpatient antibiotics. A detailed understanding of current prescribing practices is necessary to optimize antibiotic use for these conditions. METHODS: This was a retrospective cohort study of children and adults treated in the ambulatory care setting for uncomplicated cellulitis, wound infection, or cutaneous abscess between March 1, 2010 and February 28, 2011. We assessed the frequency of avoidable antibiotic exposure, defined as the use of antibiotics with broad gram-negative activity, combination antibiotic therapy, or treatment for 10 or more days. Total antibiotic-days prescribed for the cohort were compared with antibiotic-days in 4 hypothetical short-course (5-7 days), single-antibiotic treatment models consistent with national guidelines. RESULTS: A total of 364 cases were included for analysis (155 cellulitis, 41 wound infection, and 168 abscess). Antibiotics active against methicillin-resistant Staphylococcus aureus were prescribed in 61% of cases of cellulitis. Of 139 cases of abscess where drainage was performed, antibiotics were prescribed in 80% for a median of 10 (interquartile range, 7-10) days. Of 292 total cases where complete prescribing data were available, avoidable antibiotic exposure occurred in 46%. This included use of antibiotics with broad gram-negative activity in 4%, combination therapy in 12%, and treatment for 10 or more days in 42%. Use of the short-course, single-antibiotic treatment strategies would have reduced prescribed antibiotic-days by 19% to 55%. CONCLUSIONS: Approximately half of uncomplicated skin infections involved avoidable antibiotic exposure. Antibiotic use could be reduced through treatment approaches using short courses of a single antibiotic.
Authors: Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Dale Everett; Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Edward L Kaplan; Jose G Montoya; James C Wade Journal: Clin Infect Dis Date: 2005-10-14 Impact factor: 9.079
Authors: Timothy C Jenkins; Bryan C Knepper; Allison L Sabel; Ellen E Sarcone; Jeremy A Long; Jason S Haukoos; Steven J Morgan; Walter L Biffl; Andrew W Steele; Connie S Price; Philip S Mehler; William J Burman Journal: Arch Intern Med Date: 2011-02-28
Authors: Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers Journal: Clin Infect Dis Date: 2011-02-01 Impact factor: 9.079
Authors: Daniel J Pallin; William D Binder; Matthew B Allen; Molly Lederman; Siddharth Parmar; Michael R Filbin; David C Hooper; Carlos A Camargo Journal: Clin Infect Dis Date: 2013-03-01 Impact factor: 9.079
Authors: Matthew J Hepburn; David P Dooley; Peter J Skidmore; Michael W Ellis; William F Starnes; William C Hasewinkle Journal: Arch Intern Med Date: 2004 Aug 9-23
Authors: Elke Zani-Ruttenstock; Augusto Zani; Emma Bullman; Eveline Lapidus-Krol; Agostino Pierro Journal: Pediatr Surg Int Date: 2014-11-05 Impact factor: 1.827
Authors: Michael S Pulia; Rebecca J Schwei; Brian W Patterson; Michael D Repplinger; Maureen A Smith; Manish N Shah Journal: J Emerg Med Date: 2018-08-24 Impact factor: 1.484
Authors: Nick Daneman; Asgar H Rishu; Wei Xiong; Sean M Bagshaw; Deborah J Cook; Peter Dodek; Richard Hall; Anand Kumar; Francois Lamontagne; Francois Lauzier; John C Marshall; Claudio M Martin; Lauralyn McIntyre; John Muscedere; Steven Reynolds; Henry T Stelfox; Robert A Fowler Journal: Trials Date: 2015-04-18 Impact factor: 2.279
Authors: Norihiro Yogo; Gregory Gahm; Bryan C Knepper; William J Burman; Philip S Mehler; Timothy C Jenkins Journal: Front Med (Lausanne) Date: 2016-07-21
Authors: Thomas L Walsh; Lynn Chan; Chelsea I Konopka; Michael J Burkitt; Matthew A Moffa; Derek N Bremmer; Monika A Murillo; Courtney Watson; Noreen H Chan-Tompkins Journal: BMC Infect Dis Date: 2016-11-29 Impact factor: 3.090